media

Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Transgene Biotek Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
Net Profit/Loss Before Extraordinary Items And Tax-6.01-10.40-10.43-10.96-8.79
      
Net CashFlow From Operating Activities0.000.090.010.14-1.74
Net Cash Used In Investing Activities-0.01-0.10-0.030.001.74
Net Cash Used From Financing Activities0.000.000.00-0.200.00
      
Net Inc/Dec In Cash And Cash Equivalents-0.01-0.01-0.01-0.060.00
Cash And Cash Equivalents Begin of Year0.020.020.040.100.10
Cash And Cash Equivalents End Of Year0.000.020.020.040.10
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
Net Profit/Loss Before Extraordinary Items And Tax-6.01
Net CashFlow From Operating Activities0.00
Net Cash Used In Investing Activities-0.01
Net Cash Used From Financing Activities0.00
Net Inc/Dec In Cash And Cash Equivalents-0.01
Cash And Cash Equivalents Begin of Year0.02
Cash And Cash Equivalents End Of Year0.00